Ticker: BVS

Bioventus Inc. (NASDAQ: BVS) - Second Quarter 2025 Overview Bioventus Inc. has reported its second-quarter results for 2025, revealing both positive movements and challenges in its financial performance. The company specializes in medical devices aimed at addressing musculoskeletal challenges. Ke...

Bioventus Inc. (NASDAQ: BVS) has recently reported its financial performance for the quarter ended March 29, 2025, providing insight into its operational efficiency and market standing. Key Highlights: Net Sales: $123.9 million, a decrease of 4.3% compared to $129.5 million in Q1 2024. Gross Pro...